Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.
2.

Neurobehavioral actions of coumestrol and related isoflavonoids in rodents.

Whitten PL, Patisaul HB, Young LJ.

Neurotoxicol Teratol. 2002 Jan-Feb;24(1):47-54. Review.

PMID:
11836071
3.
4.

Behavioral effects of endocrine-disrupting substances: phytoestrogens.

Lephart ED, Setchell KD, Handa RJ, Lund TD.

ILAR J. 2004;45(4):443-54. Review.

PMID:
15454683
5.

[Phytoestrogens].

Kinjo J.

Nihon Rinsho. 2000 Dec;58(12):2434-8. Review. Japanese.

PMID:
11187733
6.

Soy isoflavones: are they useful in menopause?

Vincent A, Fitzpatrick LA.

Mayo Clin Proc. 2000 Nov;75(11):1174-84. Review.

PMID:
11075748
7.

Impact of dietary soy isoflavones in pregnancy on fetal programming of endothelial function in offspring.

Bonacasa B, Siow RC, Mann GE.

Microcirculation. 2011 May;18(4):270-85. doi: 10.1111/j.1549-8719.2011.00088.x. Review.

PMID:
21418378
8.

Goitrogenic and estrogenic activity of soy isoflavones.

Doerge DR, Sheehan DM.

Environ Health Perspect. 2002 Jun;110 Suppl 3:349-53. Review.

9.

Soy intake and cancer risk: a review of the in vitro and in vivo data.

Messina MJ, Persky V, Setchell KD, Barnes S.

Nutr Cancer. 1994;21(2):113-31. Review.

PMID:
8058523
10.

Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.

Rietjens IM, Sotoca AM, Vervoort J, Louisse J.

Mol Nutr Food Res. 2013 Jan;57(1):100-13. doi: 10.1002/mnfr.201200439. Epub 2012 Nov 23. Review.

PMID:
23175102
11.

Isoflavones: estrogenic activity, biological effect and bioavailability.

Vitale DC, Piazza C, Melilli B, Drago F, Salomone S.

Eur J Drug Metab Pharmacokinet. 2013 Mar;38(1):15-25. Review.

PMID:
23161396
12.

Problems for risk assessment of endocrine-active estrogenic compounds.

Safe SH, Pallaroni L, Yoon K, Gaido K, Ross S, McDonnell D.

Environ Health Perspect. 2002 Dec;110 Suppl 6:925-9. Review.

13.

Mechanisms of cancer chemoprevention by soy isoflavone genistein.

Sarkar FH, Li Y.

Cancer Metastasis Rev. 2002;21(3-4):265-80. Review.

PMID:
12549765
14.

Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis).

Cline JM, Wood CE.

Am J Primatol. 2009 Sep;71(9):722-31. doi: 10.1002/ajp.20680. Review.

PMID:
19322873
15.

Bioavailability of soy isoflavones through placental/lactational transfer and soy food.

Doerge DR.

Toxicol Appl Pharmacol. 2011 Jul 15;254(2):145-7. doi: 10.1016/j.taap.2010.10.018. Epub 2010 Oct 27. Review.

PMID:
21034763
16.

Reproductive consequences of developmental phytoestrogen exposure.

Jefferson WN, Patisaul HB, Williams CJ.

Reproduction. 2012 Mar;143(3):247-60. doi: 10.1530/REP-11-0369. Epub 2012 Jan 5. Review.

17.

Circulating levels of genistein in the neonate, apart from dose and route, predict future adverse female reproductive outcomes.

Jefferson WN, Williams CJ.

Reprod Toxicol. 2011 Apr;31(3):272-9. doi: 10.1016/j.reprotox.2010.10.001. Epub 2010 Oct 15. Review.

18.

Selecting the appropriate rodent diet for endocrine disruptor research and testing studies.

Thigpen JE, Setchell KD, Saunders HE, Haseman JK, Grant MG, Forsythe DB.

ILAR J. 2004;45(4):401-16. Review.

PMID:
15454679
19.

Genistein and daidzein: different molecular effects on prostate cancer.

Adjakly M, Ngollo M, Boiteux JP, Bignon YJ, Guy L, Bernard-Gallon D.

Anticancer Res. 2013 Jan;33(1):39-44. Review.

PMID:
23267126
20.

Genotoxicity of phytoestrogens.

Stopper H, Schmitt E, Kobras K.

Mutat Res. 2005 Jul 1;574(1-2):139-55. Epub 2005 Apr 1. Review.

PMID:
15914213

Supplemental Content

Support Center